 |
|
|
   
|
New Professional Strength Vitamin C Serums Clinically Proven to Provide up to
Two Times Greater Penetration than Leading Formulations
January 3, 2006 (Long Beach, CA) – Obagi Medical Products, Inc. (Obagi)
announced today that it is providing an unrestricted grant to the American
Society of Plastic Surgeons for research on new and improved therapies to
enhance healing and patient outcomes. It is hoped that the study of pre- and
post-skin conditioning of ablative laser procedures will result in potentially
shortened healing rates, reduced adverse events, and less visible scarring. The
research may also help identify techniques that may enhance outcomes of those
using such products for cosmetic therapeutic purposes.
“This is the first carefully constructed and monitored study conducted to
measure results of pre- and post-treatment of the skin,” said Brian Kinney, MD,
president of the Plastic Surgery Educational Foundation, the research arm of
ASPS. “We hope this research will validate anecdotal evidence that such
treatment can reduce side effects such as redness and darkening of the skin
while enhancing longer-lasting cosmetic results.”
Initial study findings are expected to be released at the ASPS annual meeting in
San Francisco in October 2006.
"We are honored to have the opportunity to create such a strong relationship
with ASPS,” said Steve Carlson, Obagi President and CEO. “This collaboration
represents an ideal way for both organizations to focus on the science of wound
healing and skin health."
The significance of these clinical trials is underscored by the estimated 9.2
million procedures performed by plastic surgeons in 2004, and all indications
suggest that these procedures continue to grow at a significant rate.
About Obagi Medical Products, Inc.
Obagi develops and commercializes skin health products for the dermatology,
plastic surgery, and related Aesthetic markets. Using its Penetrating
Therapeutics™ technologies, Obagi’s products are designed to improve penetration
of agents across the skin barrier for common and visible skin conditions in
adult skin such as chloasma, melasma, senile lentigines, acne vulgaris and sun
damage. Obagi launched its first skincare system, Obagi Nu-Derm, in 1988; and in
2004 launched the first and only prescription strength Vitamin C and
hydroquinone system, Obagi-C Rx. Obagi System products are only available
through physicians. Visit www.obagi.com for information.
About American Society of Plastic Surgery (ASPS)
The American Society of Plastic Surgeons is the largest organization of board-
certified plastic surgeons in the world. With more than 6,000 members, the
society is recognized as a leading authority and information source on cosmetic
and reconstructive plastic surgery. ASPS comprises 94 percent of all board-
certified plastic surgeons in the United States. Founded in 1931, the society
represents physicians certified by The American Board of Plastic Surgery or The
Royal College of Physicians and Surgeons of Canada.
Since 1975, the educational and research arm of the ASPS, the Plastic Surgery
Educational Foundation, has provided more than $5.3 million dollars to plastic
surgery researchers for the development of innovative procedures and treatments
that benefit reconstructive and cosmetic patients today. Funding for plastic
surgery research is made available through the ongoing financial support of ASPS
Member Surgeons who are committed to advancing the art and science of plastic
surgery.
|
|
|
|